{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:21:32Z","timestamp":1792408892716,"version":"4.4.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.lungcan.2016.03.008","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T09:16:46Z","timestamp":1459070206000},"page":"15-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation"],"prefix":"10.1016","volume":"96","author":[{"given":"Sai-Hong Ignatius","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Jalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele C.","family":"Azada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Quines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Klempner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2016.03.008_bib0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.lungcan.2015.03.022","article-title":"Radiation necrosis presenting as pseudoprogression (PsP) during alectinib treatment of previously radiated brain metastases in ALK-positive NSCLC: implications for disease assessment and management","volume":"88","author":"Ou","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2016.03.008_bib0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1470-2045(14)70362-6","article-title":"Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1\/2 study","volume":"15","author":"Gadgeel","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.2015.63.9443","article-title":"Alectinib in crizotinib-refractory ALK-rearranged non-small-cell lung cancer: a phase II global study","volume":"34","author":"Ou","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1470-2045(15)00488-X","article-title":"Phase 2 study of alectinib in ALK-positive, crizotinib-resistant non-small-cell lung cancer","volume":"17","author":"Shaw","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0025","unstructured":"S. Gadgeel, A.T. Shaw, R. Govindan, M.A. Socinski, D.R. Camidge, L. De Petris, et al., Pooled analysis of CNS response to alectinib in two studies of pre-treated ALK\u2009+\u2009NSCLC, WCLC 2015 presentation."},{"issue":"Supplement 5","key":"10.1016\/j.lungcan.2016.03.008_bib0030","article-title":"Assessing central nervous system (CNS) response to alectinib in two phase II studies of pre-treated ALK+ non-small cell lung cancer (NSCLC): RECIST versus RANO criteria","volume":"volume 17","author":"Ou","year":"2015","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.lungcan.2016.03.008_bib0035","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0040","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1200\/JCO.2008.18.4440","article-title":"Pseudoprogression in glioblastoma","volume":"26","author":"Chamberlain","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0045","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1016\/S1470-2045(13)70311-5","article-title":"Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group","volume":"14","author":"Lin","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0050","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO-HGG group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0055","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.3390\/ijms150711832","article-title":"The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence","volume":"15","author":"Parvez","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0060","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients","volume":"26","author":"Brandes","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.03.008_bib0065","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1200\/JCO.2010.34.1313","article-title":"CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib","volume":"29","author":"Costa","year":"2011","journal-title":"J. Clin. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216302549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216302549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T01:56:16Z","timestamp":1536890176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500216302549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":13,"alternative-id":["S0169500216302549"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.03.008","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}